Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer

Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer

US Patent 10894044 · Granted Jan 19, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Portable audio speaker2025
Methods of CD40 and toll like receptor immune activation2024
Monoclonal and humanized antibodies to a cancer glycopeptide2023
Methods of CD40 activation and immune checkpoint blockade2023
B and T lymphocyte attenuator marker for use in adoptive T-cell therapy2016
Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and th2012
Chimeric receptor genes and cells transformed therewith2012
Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and th2010
Activated dual specificity lymphocytes and their methods of use2010
Peptides of melanoma antigen and their use in diagnostic, prophylactic and thera2008
Methods and compositions for transforming dendritic cells and activating T cells2008
Methods and compositions for transforming dendritic cells and activating T cells2004